Evidence map›Paper›PMID 25392534›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Identification of antigen-specific B cell receptor sequences using public repertoire analysis.

Johannes Trück, Maheshi N Ramasamy, Jacob D Galson, Richard Rance, Julian Parkhill, Gerton Lunter, Andrew J Pollard, Dominic F Kelly

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 127 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Is the vaccination-induced B cell receptor repertoire predictable?Immunoinformatics (Amsterdam, Netherlands) · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Computational detection of antigen-specific B cell receptors following immunization.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Johannes Trück *Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, United Kingdom.
Maheshi N Ramasamy *Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, United Kingdom.
Jacob D GalsonOxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, United Kingdom.
Richard RanceWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, United Kingdom.
Julian ParkhillWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, United Kingdom.
Gerton LunterThe Wellcome Trust Centre for Human Genetics, Oxford OX3 7BN, United Kingdom.
Andrew J PollardOxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, United Kingdom.
Dominic F KellyOxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, United Kingdom.
National Institute for Health Research · GBWellcome Sanger Institute · GBCentre for Human Genetics · GB

Funding

Biotechnology and Biological Sciences Research Council BB/I02593X/1Wellcome TrustWellcome Trust 090532/Z/09/Z
6 · The paper itself

Abstract

High-throughput sequencing allows detailed study of the BCR repertoire postimmunization, but it remains unclear to what extent the de novo identification of Ag-specific sequences from the total BCR repertoire is possible. A conjugate vaccine containing Haemophilus influenzae type b (Hib) and group C meningococcal polysaccharides, as well as tetanus toxoid (TT), was used to investigate the BCR repertoire of adult humans following immunization and to test the hypothesis that public or convergent repertoire analysis could identify Ag-specific sequences. A number of Ag-specific BCR sequences have been reported for Hib and TT, which made a vaccine containing these two Ags an ideal immunological stimulus. Analysis of identical CDR3 amino acid sequences that were shared by individuals in the postvaccine repertoire identified a number of known Hib-specific sequences but only one previously described TT sequence. The extension of this analysis to nonidentical, but highly similar, CDR3 amino acid sequences revealed a number of other TT-related sequences. The anti-Hib avidity index postvaccination strongly correlated with the relative frequency of Hib-specific sequences, indicating that the postvaccination public BCR repertoire may be related to more conventional measures of immunogenicity correlating with disease protection. Analysis of public BCR repertoire provided evidence of convergent BCR evolution in individuals exposed to the same Ags. If this finding is confirmed, the public repertoire could be used for rapid and direct identification of protective Ag-specific BCR sequences from peripheral blood.

Indexed as

AdolescentAdultAgedAmino Acid SequenceAntibodies, BacterialBacterial CapsulesB-LymphocytesHaemophilus influenzae type bHaemophilus VaccinesHigh-Throughput Nucleotide SequencingHumansImmunoglobulin AImmunoglobulin GImmunoglobulin Heavy ChainsImmunoglobulin MMeningococcal VaccinesAntibodies, BacterialHaemophilus influenzae type b polysaccharide vaccineHaemophilus VaccinesImmunoglobulin AImmunoglobulin GImmunoglobulin Heavy ChainsImmunoglobulin Mmeningococcal group C polysaccharidemeningococcal group C polysaccharide-tetanus toxoid conjugateMeningococcal VaccinesPolysaccharides, BacterialReceptors, Antigen, B-CellTetanus ToxoidVaccines, CombinedVaccines, Conjugate

Identifiers

PMID25392534
PMCPMC4272858
OpenAlexW1545131818

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.